Literature DB >> 24094490

Neuropeptides to replace serum in cryopreservation of mesenchymal stromal cells?

Alexandra Briquet1, Amélie Halleux, Chantal Lechanteur, Yves Beguin.   

Abstract

BACKGROUND AIMS: The therapeutic potential of human mesenchymal stromal cells (MSCs) has generated considerable interest in a wide variety of areas. MSC banking is feasible, but the optimal technique of cryopreservation remains to be determined.
METHODS: To reduce dimethyl sulfoxide (DMSO) concentration in cryopreservation medium, DMSO was replaced with sucrose or trehalose. To increase cell survival and proliferation rates after thawing and to eliminate the need for fetal bovine serum (FBS), neuropeptides of the vasoactive intestinal peptide/glucose-dependent insulinotropic peptide/pituitary adenylate cyclase activating polypeptide family were added to the cryopreservation medium. Cell survival was analyzed by a trypan blue dye exclusion assay. Cell proliferation of cryopreserved MSCs was determined after 7 days of culture.
RESULTS: No significant differences in cell survival rates were detected between cryopreservation solutions with 5% and 10% DMSO, independently of the addition of trehalose or sucrose. Cell proliferation rates tended to be highest when MSCs were frozen in 5% DMSO + trehalose. FBS could be replaced by human albumin (HA) without loss in cell survival and proliferation potential. With FBS, the addition of neuropeptides could increase cell survival and proliferation rates. Without FBS or HA, cell survival and proliferation rates in the presence of neuropeptides were comparable to rates achieved with FBS or HA.
CONCLUSIONS: Classic cryopreservation with 10% DMSO could be replaced by 5% DMSO + 30 mmol/L trehalose. FBS could be replaced by HA or neuropeptides without loss in cell survival and proliferation potential. The addition of neuropeptides in the cryopreservation medium containing FBS could increase the cell proliferation rate and consequently cellular output.
Copyright © 2013 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  GIP; PACAP; VIP; cryopreservation; mesenchymal stromal cells; neuropeptides

Mesh:

Substances:

Year:  2013        PMID: 24094490     DOI: 10.1016/j.jcyt.2013.06.012

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  4 in total

Review 1.  Taking a bite out of spinal cord injury: do dental stem cells have the teeth for it?

Authors:  John Bianco; Pauline De Berdt; Ronald Deumens; Anne des Rieux
Journal:  Cell Mol Life Sci       Date:  2016-01-14       Impact factor: 9.261

Review 2.  Cryopreservation of Tissue-Engineered Scaffold-Based Constructs: from Concept to Reality.

Authors:  Irina Arutyunyan; Andrey Elchaninov; Gennady Sukhikh; Timur Fatkhudinov
Journal:  Stem Cell Rev Rep       Date:  2021-11-10       Impact factor: 6.692

Review 3.  Local and targeted drug delivery for bone regeneration.

Authors:  Maureen R Newman; Danielle Sw Benoit
Journal:  Curr Opin Biotechnol       Date:  2016-04-08       Impact factor: 9.740

4.  Comparison of the Effects of Different Cryoprotectants on Stem Cells from Umbilical Cord Blood.

Authors:  Gecai Chen; Aihuan Yue; Zhongbao Ruan; Yigang Yin; Ruzhu Wang; Yin Ren; Li Zhu
Journal:  Stem Cells Int       Date:  2015-12-07       Impact factor: 5.443

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.